Molecular pathogenesis of Burkitt lymphoma: the role of c-MYC
Therapeutic strategies in lymphoma based on oncogenic B receptor signaling
Prevention and treatment of tumor lysis syndrome in the rasburicase era
Treatment and prognosis of childhood and adolescent B-NHL: LMB and BFM perspective
Improved outcomes in CNS-positive pediatric Burkitt lymphoma/leukemia using rituximab plus FAB group C1 chemotherapy without CNS radiation: a Children's Oncology Group report
Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia: dose-escalation does not increase the response rate
Rituximab with B-NHL-BFM 95 protocol as a first-line treatment in children with B-NHL
Genetic pathways and targeted therapies in T-ALL
Phospho flow cytometry: a path to novel targets
MicroRNAs and pediatric non-Hodgkin lymphoma (NHL)
Zebrafish: a novel approach to understanding lymphomagenesis and treatment responses
Sequencing of pediatric Burkitt lymphoma within the ICGC MMML-Seq project
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes
Biopathology of peripheral T/NK cell lymphoma
Autologous and allogeneic stem cell transplantation of peripheral T/NK cell non-Hodgkin's lymphoma
Stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma in Japan
Clinical characteristics and outcome of pediatric and adolescent patients with follicular lymphoma - The EICNHL and i-BFM study groups experience
Monoclonal antibody and targeted cellular immunotherapy for childhood, adolescent and young adult lymphoma
Promising new novel targeted therapy for NHL
Novel approaches to prophylaxis and treatment of CNS NHL in children adolescents and young adults
Intratumoral Treg immunomodulation at a single site cures disseminated disease including in the brain
Aberrant MAPK and PI3K signaling contribute to chemotherapy resistance in T cell acute lymphoblastic leukemia/lymphoma by altering the balance of apoptosis mediators
Significant cord blood NK cell expansion, activation and in-vitro and in-vivo cytotoxicity against B-NHL following stimulation with genetically re-engineered K562MBIL15-41BBL (MODK562): potential for adoptive cellular immunotherapy
Minimal residual disease monitoring
Molecular biology for the clinician: diffuse large B cell Lymphoma as a model
Lymphoblastic lymphoma
Treatment and prognosis of childhood and adolescent ALCL: European perspective
Biologically based risk factors in ALCL: minimal disease and immune response against ALK
Biopathology of childhood and adolescent anaplastic large cell lymphoma
Anaplastic large cell lymphoma stem cells possess a gene expression profile reflective of an early thymic progenitor pointing to a primitive cell of origin
Identification of Snps and Indels mutation in ALK kinase domain by 454 massive parallel pyrosequencing
Pretreatment plasma cytokine levels in children with anaplastic large cell lymphoma
Diagnosis and treatment of PMBL and gray zone lymphoma in AYA patients
Clinical, pathological and molecular features of pediatric follicular lymphoma
Comparison of clinical presentation and outcome of adolescents versus younger children with mature B-NHL registered in the SEER database
Genetic aberrations in pediatric follicular lymphoma
Primary mediastinal large B-cell lymphoma in Pediatric Patients (PMBCL): a retrospective analysis and outcome after LMB 89-96- 2001 SFOP- SFCE protocols, with and without rituximab
Modeling EBV driven immune surveillance and lymphomagenesis in mice
EBV cytotoxic lymphocytes (CTL's) in the treatment of human lymphomas
Safety and pharmacokinetics of rituximab in combination with FAB chemotherapy in children and adolescents with Stage III/IV mature B-NHL and B-cell leukemia +/- CNS disease: a Children's Oncology Group Report
Identification of NPM-ALK-reactive T cells in children with NPM-ALK-positive anaplastic large cell lymphoma (ALCL)
Outcome of advanced stage (III/IV) intermediate-risk patients with mature B-NHL using rituximab plus FAB group B4 chemotherapy: a Children's Oncology Group report
Pediatric B-cell non-Hodgkin lymphomas (NHL): final results of the Italian AIEOP LNH-97 protocol
Clinical outcome of 319 children with non-hodgkin lymphoma treated in a single center in China
Clinical characteristics and outcome of ALK positive diffuse large B-cell non Hodgkin lymphoma
The efficacy of rasburicase during COP reduction for the prevention of TLS in children and adolescents with newly diagnosed advanced stage mature B-NHL: a Children's Oncology Group report
A comparison of autologous and allogeneic stem cell transplantation for pediatric mature B-cell Non-Hodgkin lymphoma
Safety of liposomal cytarabine prophylaxis in pediatric bone marrow transplant recipients with acute leukemia (AL) or non Hodgkin lymphoma (NHL) at high risk of CNS relapse
Minimal residual disease in patients with anaplastic large cell lymphoma correlates with histological subtype and outcome
Quantification of minimal disseminated disease in NPM-ALK positive anaplastic large cell lymphoma by real-time-PCR and flow cytometry
EBV-specific T cell immunity in pediatric post-transplant lymphoproliferative disease after organ transplantation
Unmanipulated donor lymphocytes infusion for EBV-related post-transplant lymphoproliferative disorder (PTLD) after HLA-haploidentical Transplantation in thalassemic patients
Immunophenotypic and cytogenetic analysis in advanced precursor T-cell lymphoblastic lymphoma (T-LBL) of children and adolescents; a Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) report
The B-cell oncogene UCH-L1 orchestrates competing mTOR complexes
ATM-independent functions for 53BP1 in lymphoma suppression
Obinutuzumab (GA101): exhibits enhanced cell death and ADCC compared to Rituximab in RTX resistant and sensitive cell lines against B-cell non-Hodgkin lymphoma
Glycoproteomic signature of NPM-ALK (+) anaplastic large cell lymphoma
Inhibitory effect of ruxolitinib (JAK1/2 inhibitor) on JAK2 signaling, proliferation and induction of apoptosis in Hodgkin (HL) and primary mediastinal B-cell (PMBL) adolescent and young adult (AYA) lymphomas
Anaplastic large cell lymphoma of childhood
Adolescent and young adult unit/program
Post-transplant lymphoproliferative disease
Hodgkin lymphoma
New staging classification for pediatric NHL
T-ALL and T-lymphoblastic lymphoma (T-LBL) the same or different diseases?
Treatment and prognosis of advanced stage lymphoblastic lymphoma
Mutations in NOTCH1 and/or FBXW7 predict favorable outcome and a decreased risk of relapse in a cohort of more than 100 pediatric T-cell lymphoblastic lymphoma patients
Dexamethasone (DEX) versus prednisone (PRED) in T-cell non Hodgkin lymphoma (T-NHL): results of the randomized phase III trial 58951 of the EORTC Children Leukemia Group
Results of the European intergroup trial EURO-LB02 on lymphoblastic lymphoma (LBL) in children/adolescents
Deregulated microRNA expression in childhood T-cell lymphoblastic lymphoma
Re-induction approaches to relapsed/refractory childhood and adolescent non Hodgkin's lymphoma: BFM perspective
Pediatric PTLD following solid organ transplantation (SOT), beyond the COG trial
Stem cell transplantation for children, adolescents and young adults with relapsed/refractory Non-Hodgkin lymphoma
Risk-adapted therapy for patients with relapsed or refractory ALCL - interim-results of the prospective EICNHL-Trial ALCL-relapse
Role of hematopoietic stem cell transplantation for relapsed or refractory pediatric non-Hodgkin lymphomas
Low-dose chemotherapy and rituximab for post-transplant lymphoproliferative disease (PTLD): a Children's Oncology Group report*
In childhood B-cell non Hodgkin's lymphoma (B-NHL) and mature B-cell acute leukemia (B-AL) with CNS disease at diagnosis, patients with blasts in CSF are at higher risk of event
Results of second-look surgery for residual tumor towards the end of B-NHL BFM chemotherapy
Feasibility and efficacy of immunochemotherapy for the treatment of mature B-cell leukemia: a report from the Children's Oncology Group
Burkitt lymphoma of mediastinum: an unusual localization at diagnosis in childhood
Outcome of acute B-cell lymphoblastic leukemia of childhood treated with ALEOP LNH-97 protocol
Risk-adapted stratification for optimally intensive treatment assignment of pediatric patients with NHL is an effective strategy in developing countries (Dc)
Adjusted LMB96 LNH protocol for children with B-cell non-Hodgkin's lymphoma: 2006-2010 experience at the Children Welfare Teaching Hospital (CWTH) in Baghdad
Precursor-B acute lymphoblastic leukemia (ALL) FAB-L3 morphology with 8q24 abnormalities in childhood
The outcome of childhood non-Hodgkin lymphoma: 13-year experience in Slovakia
Clinical characteristics of pediatric Burkitt's lymphoma: experiences in 83 patients treated according to LMB protocol in China
Racial and ethnic disparities in survival of Israeli children with lymphomas: the experience of the Israel Society of Pediatric Hematology Oncology Group
Burkitt's lymphoma in children: 40 years results of a single center from a developing country
Long-term results of the Milan chemotherapy program for advanced childhood Burkitt lymphoma
Characteristics and outcome of children with ovarian infiltration of non-Hodgkin lymphoma (NHL)
Why EFS for patients with B-ALL is alarmingly lower than for patients with NHL-B in Polish Pediatric Leukemia/Lymphoma Study Group?
Long-term results of intensified chemotherapy inspired by a high-risk acute lymphoblastic leukemia protocol for non-hodgkin lymphoma in children
Role of surgery in stages II and III pediatric abdominal non-Hodgkin lymphoma: a 5-years experience
Overview of childhood lymphoma in Mandalay
Clinical and paraclinical characteristics and treatment result of children Burkitt's lymphomas in Viet Nam National Cancer Hospital
USP44 is a regulator of centrosome separation and is commonly over-expressed in childhood T-cell lymphoblastic leukemia/lymphoma
A retrospective study to evaluate the value of positron emission tomography/computed tomography with fluorine-18-2- fluoro-2-deoxy-D-glucose in childhood non-Hodgkin's lymphoma
Plasma cell-free DNA in paediatric lymphomas
Discrepancies between BM-infiltration in multiple BM aspirates in pediatric NHL-patients - a BFM-group report
PTEN expression is decreased in pediatric Burkitt lymphoma
Does minimal residual disease (MRD) predict relapse in children with advance B-NHL treated with chemoimmunotherapy: a children's oncology report
Role of Ikaros and CK2 kinase in human B-cell lymphoma
Tissular cytokine and chemokine receptor expression in Burkitt lymphoma (BL) and diffuse large B cell lymphoma (DLBCL)
DLEU1 TALENS-mediated loss of function in Burkitt lymphoma (BL) Raji cells: implication of IncRNA DLEU1 gene as a tumor suppressor gene
Silencing of long non-coding RNA DLEU1 gene by transcription activator-like effector nucleases (TALENS) in Burkitt lymphoma cells
High-resolution genome-wide analysis of endemic Burkitt Lymphoma using DNA extracted from fineneedle aspirates preserved at ambient temperature
Post-transplant lymphoproliferative disorders in pediatric bone marrow transplant recipients have non-germinal center-B phenotype and unique cytogenetic abnormalities
Analysis of immunoglobulin heavy chain rearrangement in a child with recurrent Burkitt's lymphoma to determine clonality
B-cell acute leukemia cases with discordant flow cytometry, cytomorphology and cytogenetics data
Classical and molecular cytogenetic studies revealed cryptic chromosomal abnormalities and heterogenity of IGH/MYC gene fusion in Brazilian childhood Burkitt Lymphoma cases
Epstein-Barr virus-positive childhood B-cell non-Hodgkin' S lymphoma demonstrates frequent aberrant methylation Of P16ink4a but not Bim gene
Primary leptomeningeal non-Hodgkin lymphoma (PLML) in childhood
Peripheral T-cell lymphoma in children, reporting two cases
Hydroa-like cutaneous T-cell lymphoma: clinicopathologic and treatment characateristics of four pediatric cases from Edgardo Rebagliati Martins Hospital from Perú
Results of immunochemotherapy of pediatric mature B-cell Leukemia
Pediatric clinical trial and compassionate use experience with glucarpidase for methotrexate toxicity
Overcoming rituximab-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: direct cytotoxicity, chemo-immuno-sensitization and cell signaling
Preclinical therapeutic effectiveness of the combination of galiximab (Anti-CD80 mAb) and chemotherapy in the treatment of B-NHL: mechanism of action
Reduced burden of oncologic therapy in advanced B-cell lymphoma (REBOOT ABLY) in children, adolescents and young adults with CD20+ mature B-cell lymphoma
Advantages of proton therapy in the management of primary mediastinal B-cell lymphoma (PMBCL)
Expression of CD8 and pSTAT3 is associated with the morphological subtype and outcome in pediatric ALK-positive anaplastic large cell lymphoma - an immunofluorescence multi-staining study
Hemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma: incidence, clinical features and outcome
Microarray facilitates cytogenetic definition of secondary abnormalities in ALCL
Brentuximab Vedotin (SGN 35): prolonged remission in a teen-ager with multiply relapsed Anaplastic Large Cell Lymphoma
Review of treatment in 69 children with Anaplastic Large Cell Lyphoma (ALCL) treated according to ALCL 99 protocol in Poland
Review of anaplastic large cell lymphoma in a single institution
Socioeconomic status and survival among children with Hodgkin's and non-Hodgkin's lymphomas in Ontario
Reduced intensity allogeneic stem cell transplantation followed by adoptive cellular immunotherapy with donor derived LMP specific-CTLs in patients with EBV positive refractory or recurrent hodgkin lymphoma: a lymphoma cell therapy consortium trial
Da-Epoch-R and Epoch-R in treatment of adolescent patients with DLBCL
Intensive chemotherapy improves an outcome of adolescents and young adults with germinal Center Bcell-like subtype of diffuse large B-cell lymphoma (DLBCL)
Lymphoma patients secondary to congenital and acquired immunodeficiency syndromes in a Turkish Pediatric Oncology Center
Outcomes and treatment of non-Hodgkin's lymphoma (NHL) in teenage/adolescent in Paediatric centers - a South East Asian perspective
Lymphoma in adolescent -analysis in center of reference in cancer in the West of the Parana State -Brazil
Natural Killer (NK) cells successfully transduced with an anti-CD20 chimeric antigen receptor (CAR) by mRNA nucleofection have significant cytotoxicity against CD20+ non-Hodgkin's lymphoma (NHL)
Chromosome 6q deletions as an unfavorable prognostic marker in pediatric T-cell lymphoblastic lymphoma: update and establishment of a new, convenient and reliable method
High-resolution copy number analysis of B-lymphoblastic lymphoma using tissue from archived glass slides
Adverse outcome for childrens and adolescents with T-cell lymphoblastic lymphoma
The therapeutic effect and prognostic study of 73 children with T-cell lymphoblastic lymphoma
Posterior reversible encephalopathy syndrome in patients with lymphoid malignancies of childhood
Pediatric CNS post transplant lymphoproliferative disorder (PTLD) treated with high intensity combined chemo-immunotherapy
Late events in pediatric T-cell lymphoblastic lymphoma: Distinction of late relapse from secondary malignancy by molecular methods?
Salvage of multiply relapsed Burkitt's non-Hodgkin lymphoma by matched-unrelated donor haematopoietic stem cell transplantation
Post-transplantation lymphoproliferative disorder in children: a single centre experience
Severe complications with persistent hypogammaglobulinemia following rituximab therapy for relapsed diffuse large B-cell lymphoma
Rituximab treatment in B-cell NHL children in two Brazilian institutions
Chemotherapy response of refractory T-cell lymphoma in a patient with calpain deficiency
Pediatric cutaneous B cell lymphoma: two cases
Pediatric follicular lymphoma presenting as a rectal polyp
Primary cerebral burkitt lymphoma (PCBL) in a 16-year-old boy
Primary bone lymphoma in a young adult patient: a chromothripsis event?
Role of second look surgery in residual abdominal mass in mature B-cell non Hodgkin's lymphoma in children
Diffuse large B cell lymphoma with ovarian involvement in a 4 year old girl